Cargando…
Preferences for pre-exposure prophylaxis for HIV: A systematic review of discrete choice experiments
BACKGROUND: We aimed to systematically review the health preference literature using discrete choice experiments (DCEs), an attribute-based stated preference method, to investigate patient preferences for HIV pre-exposure prophylaxis (PrEP). METHODS: A search in PubMed, Scopus, CINAHL, and Embase wa...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9284393/ https://www.ncbi.nlm.nih.gov/pubmed/35844771 http://dx.doi.org/10.1016/j.eclinm.2022.101507 |
_version_ | 1784747553078640640 |
---|---|
author | Wulandari, Luh Putu Lila He, Shi Yi Fairley, Christopher K. Bavinton, Benjamin R. Marie-Schmidt, Heather Wiseman, Virginia Guy, Rebecca Tang, Weiming Zhang, Lei Ong, Jason J. |
author_facet | Wulandari, Luh Putu Lila He, Shi Yi Fairley, Christopher K. Bavinton, Benjamin R. Marie-Schmidt, Heather Wiseman, Virginia Guy, Rebecca Tang, Weiming Zhang, Lei Ong, Jason J. |
author_sort | Wulandari, Luh Putu Lila |
collection | PubMed |
description | BACKGROUND: We aimed to systematically review the health preference literature using discrete choice experiments (DCEs), an attribute-based stated preference method, to investigate patient preferences for HIV pre-exposure prophylaxis (PrEP). METHODS: A search in PubMed, Scopus, CINAHL, and Embase was conducted on July 1, 2021, and updated on November 3, 2021. We used two concepts to create our search strategy: (1) discrete choice experiments/conjoint analysis/best-worst scaling, and (2) HIV PrEP.The study is registered in PROSPERO (CRD42021267026). FINDINGS: In total, 1060 studies were identified, and 18 were included in the analysis. Various attributes were examined, including dosing regimen, type of PrEP products, side effects, other side benefits, cost, effectiveness, dispensing venue, and additional support services. Dosing frequency, cost, the effectiveness of PrEP, dispensing venue, and side effects were the most common attributes examined in DCEs. Despite significant heterogeneity in preferences across subpopulations, overall, the most important attributes were cost (28%, 5/18), effectiveness (28%, 5/18) followed by dosing frequency (17%, 3/18). INTERPRETATION: Notably, in studies where all of these three attributes were examined, some individuals would trade effectiveness for cost or vice versa. Ensuring PrEP is low cost or free, widely disseminating information of its effectiveness and advancements in reducing dosing frequency could accelerate the uptake of PrEP for those who would benefit from PrEP the most. FUNDING: None. |
format | Online Article Text |
id | pubmed-9284393 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Elsevier |
record_format | MEDLINE/PubMed |
spelling | pubmed-92843932022-07-16 Preferences for pre-exposure prophylaxis for HIV: A systematic review of discrete choice experiments Wulandari, Luh Putu Lila He, Shi Yi Fairley, Christopher K. Bavinton, Benjamin R. Marie-Schmidt, Heather Wiseman, Virginia Guy, Rebecca Tang, Weiming Zhang, Lei Ong, Jason J. eClinicalMedicine Review BACKGROUND: We aimed to systematically review the health preference literature using discrete choice experiments (DCEs), an attribute-based stated preference method, to investigate patient preferences for HIV pre-exposure prophylaxis (PrEP). METHODS: A search in PubMed, Scopus, CINAHL, and Embase was conducted on July 1, 2021, and updated on November 3, 2021. We used two concepts to create our search strategy: (1) discrete choice experiments/conjoint analysis/best-worst scaling, and (2) HIV PrEP.The study is registered in PROSPERO (CRD42021267026). FINDINGS: In total, 1060 studies were identified, and 18 were included in the analysis. Various attributes were examined, including dosing regimen, type of PrEP products, side effects, other side benefits, cost, effectiveness, dispensing venue, and additional support services. Dosing frequency, cost, the effectiveness of PrEP, dispensing venue, and side effects were the most common attributes examined in DCEs. Despite significant heterogeneity in preferences across subpopulations, overall, the most important attributes were cost (28%, 5/18), effectiveness (28%, 5/18) followed by dosing frequency (17%, 3/18). INTERPRETATION: Notably, in studies where all of these three attributes were examined, some individuals would trade effectiveness for cost or vice versa. Ensuring PrEP is low cost or free, widely disseminating information of its effectiveness and advancements in reducing dosing frequency could accelerate the uptake of PrEP for those who would benefit from PrEP the most. FUNDING: None. Elsevier 2022-07-09 /pmc/articles/PMC9284393/ /pubmed/35844771 http://dx.doi.org/10.1016/j.eclinm.2022.101507 Text en © 2022 The Authors https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
spellingShingle | Review Wulandari, Luh Putu Lila He, Shi Yi Fairley, Christopher K. Bavinton, Benjamin R. Marie-Schmidt, Heather Wiseman, Virginia Guy, Rebecca Tang, Weiming Zhang, Lei Ong, Jason J. Preferences for pre-exposure prophylaxis for HIV: A systematic review of discrete choice experiments |
title | Preferences for pre-exposure prophylaxis for HIV: A systematic review of discrete choice experiments |
title_full | Preferences for pre-exposure prophylaxis for HIV: A systematic review of discrete choice experiments |
title_fullStr | Preferences for pre-exposure prophylaxis for HIV: A systematic review of discrete choice experiments |
title_full_unstemmed | Preferences for pre-exposure prophylaxis for HIV: A systematic review of discrete choice experiments |
title_short | Preferences for pre-exposure prophylaxis for HIV: A systematic review of discrete choice experiments |
title_sort | preferences for pre-exposure prophylaxis for hiv: a systematic review of discrete choice experiments |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9284393/ https://www.ncbi.nlm.nih.gov/pubmed/35844771 http://dx.doi.org/10.1016/j.eclinm.2022.101507 |
work_keys_str_mv | AT wulandariluhputulila preferencesforpreexposureprophylaxisforhivasystematicreviewofdiscretechoiceexperiments AT heshiyi preferencesforpreexposureprophylaxisforhivasystematicreviewofdiscretechoiceexperiments AT fairleychristopherk preferencesforpreexposureprophylaxisforhivasystematicreviewofdiscretechoiceexperiments AT bavintonbenjaminr preferencesforpreexposureprophylaxisforhivasystematicreviewofdiscretechoiceexperiments AT marieschmidtheather preferencesforpreexposureprophylaxisforhivasystematicreviewofdiscretechoiceexperiments AT wisemanvirginia preferencesforpreexposureprophylaxisforhivasystematicreviewofdiscretechoiceexperiments AT guyrebecca preferencesforpreexposureprophylaxisforhivasystematicreviewofdiscretechoiceexperiments AT tangweiming preferencesforpreexposureprophylaxisforhivasystematicreviewofdiscretechoiceexperiments AT zhanglei preferencesforpreexposureprophylaxisforhivasystematicreviewofdiscretechoiceexperiments AT ongjasonj preferencesforpreexposureprophylaxisforhivasystematicreviewofdiscretechoiceexperiments |